( We provide with SLC3A2 qPCR primers for gene expression analysis, HP105164 )
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
Human influenza hemagglutinin (HA) is a surface glycoprotein required for the infectivity of the human virus. The HA tag is derived from the HA-molecule corresponding to amino acids 98-106 has been extensively used as a general epitope tag in expression vectors. Many recombinant proteins have been engineered to express the HA tag, which does not appear to interfere with the bioactivity or the biodistribution of the recombinant protein. This tag facilitates the detection, isolation, and purification of the proteins.
The actual HA tag is as follows: 5' TAC CCA TAC GAT GTT CCA GAT TAC GCT 3' or 5' TAT CCA TAT GAT GTT CCA GAT TAT GCT 3' The amino acid sequence is: YPYDVPDYA.
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), C-GFPSpark 標籤||HG16415-ACG|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), C-OFPSpark 標籤||HG16415-ACR|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), C-Flag 標籤||HG16415-CF|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), C-His 標籤||HG16415-CH|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), C-Myc 標籤||HG16415-CM|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), C-HA 標籤||HG16415-CY|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF(克隆載體)||HG16415-G|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), N-Flag 標籤||HG16415-NF|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), N-His 標籤||HG16415-NH|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), N-Myc 標籤||HG16415-NM|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體), N-HA 標籤||HG16415-NY|
|人 CD98/SLC3A2/4F2HC 基因全長cDNA ORF克隆 (表達載體)||HG16415-UT|
4F2 cell-surface antigen heavy chain, also known as 4F2 heavy chain antigen, Lymphocyte activation antigen 4F2 large subunit, CD98, SLC3A2 and MDU1, is a single-pass type I I membrane protein which belongs to the SLC3A transporter family. SLC3A2 / MDU1 is expressed ubiquitously in all tissues tested with highest levels detected in kidney, placenta and testis and weakest level in thymus. During gestation, expression in the placenta is significantly stronger at full-term than at the mid-trimester stage. SLC3A2 / MDU1 is expressed in HUVECS and at low levels in resting peripheral blood T-lymphocytes and quiescent fibroblasts. It is expressed in fetal liver and in the astrocytic process of primary astrocytic gliomas. SLC3A2 / MDU1 is also expressed in retinal endothelial cells and in the intestinal epithelial cell line Caco2-BBE. SLC3A2 / MDU1 is required for the function of light chain amino-acid transporters. It involved in sodium-independent, high-affinity transport of large neutral amino acids such as phenylalanine, tyrosine, leucine, arginine and tryptophan. SLC3A2 / MDU1 is involved in guiding and targeting of LAT1 and LAT2 to the plasma membrane. When associated with SLC7A6 or SLC7A7, SLC3A2 / MDU1 acts as an arginine/glutamine exchanger, following an antiport mechanism for amino acid transport, influencing arginine release in exchange for extracellular amino acids. SLC3A2 / MDU1 plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. It is required for normal and neoplastic cell growth. When associated with SLC7A5/LAT1, SLC3A2 / MDU1 is also involved in the transport of L-DOPA across the blood-brain barrier, and that of thyroid hormones triiodothyronine (T3) and thyroxine (T4) across the cell membrane in tissues such as placenta.